K KNACK PHARMACEUTICALS YOUR HEALTH PARTNER
DEAD

Serial Number

97425841

Owner

Knack Pharmaceuticals, Inc.

Attorney

Tomas M. Casalins

Filing Date

May 24, 2022

Add to watchlist:

No watchlists yet
View on USPTO

K KNACK PHARMACEUTICALS YOUR HEALTH PARTNER Trademark

Serial Number: 97425841

K KNACK PHARMACEUTICALS YOUR HEALTH PARTNER is a trademark filed by Knack Pharmaceuticals, Inc. on May 24, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

Knack Pharmaceuticals, Inc.

885 Third Avenue, 17th Floor
New York, NY 10022

Entity Type: 03

Trademark Details

Filing Date

May 24, 2022

Registration Date

Not Registered

Published for Opposition

April 25, 2023

Goods & Services

Pharmaceutical preparations for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations for the treatment and prevention of neurodegenerative diseases and disorders; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of pain and neuropathic pain; Pharmaceutical preparations for the treatment and prevention of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of respiratory system diseases and disorders; Pharmaceutical preparations for the treatment and prevention of skin diseases, allergies and rheumatic disorders; Pharmaceutical preparations for the treatment and prevention of sexual dysfunction; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Pharmaceutical preparations for the treatment and prevention of Alzheimer's disease; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of ophthalmic related disorders and diseases; Pharmaceutical preparations for the treatment and prevention of musculoskeletal related diseases and disorders; Pharmaceutical preparations for the treatment and prevention of hormone disorders and deficiencies; Pharmaceutical preparations for the treatment and prevention of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the treatment and prevention of metabolic, endocrine and kidney related diseases and disorders; Pharmaceutical preparations for the treatment and prevention of nausea and vomiting; Pharmaceutical preparations for the treatment and prevention of AIDS-related disorders and diseases; Pharmaceutical preparations for the treatment and prevention of viral and bacterial infections; Pharmaceutical preparations for the treatment of exposure to toxic agents; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the support and promotion of bone strength and health; Pharmaceutical preparations for use as injectable anesthetics; Pharmaceutical preparations for use as contraceptives; Pharmaceutical preparations for fertility enhancement purposes; Pharmaceutical preparations for use in hormone replacement therapy; Pharmaceutical preparations for inducing labor and facilitating nursing; Pharmaceutical preparations, namely, injectable contraceptives

Advertising planning; Advertising services, public relations and marketing services, namely, promoting and marketing the goods and services of others through all public communication means; Business management; Business operation, business administration and office functions

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jul 27, 2026 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jul 27, 2026 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 9, 2026 EXRA
SOU EXTENSION 5 GRANTED
May 8, 2026 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 8, 2026 AITU
SOU TEAS EXTENSION RECEIVED
Dec 10, 2025 EEXT
SOU EXTENSION 5 FILED
Dec 9, 2025 EXT5
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 21, 2025 EXRA
SOU EXTENSION 4 GRANTED
Jun 20, 2025 EX4G
SOU EXTENSION 4 FILED
Jun 20, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
Jun 20, 2025 EEXT
SOU EXTENSION 3 GRANTED
Dec 14, 2024 EX3G
SOU EXTENSION 3 FILED
Dec 14, 2024 EXT3
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 13, 2024 EXRA
SOU TEAS EXTENSION RECEIVED
Dec 13, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 18, 2024 EXRA
SOU EXTENSION 2 GRANTED
Jun 18, 2024 EX2G
SOU EXTENSION 2 FILED
Jun 18, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Jun 18, 2024 EEXT
ASSIGNED TO EXAMINER
May 1, 2024 DOCK
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 21, 2023 EXRA
SOU EXTENSION 1 GRANTED
Dec 19, 2023 EX1G
SOU EXTENSION 1 FILED
Dec 19, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 19, 2023 EEXT
ASSIGNED TO EXAMINER
Nov 13, 2023 DOCK
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 20, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 25, 2023 NPUB
PUBLISHED FOR OPPOSITION
Apr 25, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 5, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 17, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 16, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 16, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 16, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 16, 2023 CNEA
ASSIGNED TO EXAMINER
Mar 12, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 31, 2022 NWOS
NEW APPLICATION ENTERED
May 27, 2022 NWAP